• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽的前药。9. 肽键的生物可逆N-α-羟烷基化以实现对羧肽酶或其他蛋白水解酶的保护。

Prodrugs of peptides. 9. Bioreversible N-alpha-hydroxyalkylation of the peptide bond to effect protection against carboxypeptidase or other proteolytic enzymes.

作者信息

Bundgaard H, Rasmussen G J

机构信息

Royal Danish School of Pharmacy, Department of Pharmaceutical Chemistry, Copenhagen, Denmark.

出版信息

Pharm Res. 1991 Mar;8(3):313-22. doi: 10.1023/a:1015833229554.

DOI:10.1023/a:1015833229554
PMID:2052517
Abstract

Various N-alpha-hydroxyalkyl derivatives of N-acyl amino acids and di- and tripeptides were prepared by hydrolysis or aminolysis of N-acyl 5-oxazolidinones. The stability of these derivatives was studied in aqueous solution as a function of pH. The compounds were all degraded quantitatively to their parent N-acylated amino acid or peptide and aldehyde but with vastly different rates. At pH 7.4 and 37 degrees C the half-lives of decomposition ranged from 4 min to 1500 hr. The structural factors influencing the stability included both steric and polar effects within the acyl and N-alpha-hydroxyalkyl moieties as well as within the amino acid attached to the N-alpha-hydroxyalkylated N-acyl amino acid. Whereas the N-benzyloxycarbonyl (Z) derivatives of the dipeptides Gly-L-Leu and Gly-L-Ala were readily hydrolyzed by carboxypeptidase A, the N-hydroxymethylated compounds, i.e., Z-Gly(CH2OH)-Leu and Z-Gly(CH2OH)-Ala, were resistant to cleavage by the enzyme as revealed by their similar rates of decomposition in the presence or absence of the enzyme at pH 7.4 and 37 degrees C. The results suggest that N-alpha-hydroxyalkylation of a peptide bond protects not only this bond but also an adjacent peptide bond against proteolytic cleavage. Since the N-alpha-hydroxyalkyl derivatives are readily bioreversible, undergoing spontaneous hydrolysis at physiological pH, this prodrug approach promises to overcome the enzymatic barrier to absorption of various peptides.

摘要

通过N-酰基-5-恶唑烷酮的水解或氨解反应制备了N-酰基氨基酸以及二肽和三肽的各种N-α-羟烷基衍生物。研究了这些衍生物在水溶液中作为pH函数的稳定性。这些化合物都定量降解为其母体N-酰化氨基酸或肽以及醛,但降解速率差异很大。在pH 7.4和37℃下,分解半衰期范围为4分钟至1500小时。影响稳定性的结构因素包括酰基和N-α-羟烷基部分以及连接到N-α-羟烷基化N-酰基氨基酸上的氨基酸内的空间效应和极性效应。二肽Gly-L-Leu和Gly-L-Ala的N-苄氧羰基(Z)衍生物很容易被羧肽酶A水解,而N-羟甲基化化合物,即Z-Gly(CH2OH)-Leu和Z-Gly(CH2OH)-Ala,在pH 7.4和37℃下,无论有无该酶存在,其分解速率相似,表明它们对该酶的裂解具有抗性。结果表明,肽键的N-α-羟烷基化不仅保护该键,还保护相邻的肽键免受蛋白水解裂解。由于N-α-羟烷基衍生物很容易发生生物可逆反应,在生理pH下会自发水解,这种前药方法有望克服各种肽吸收的酶屏障。

相似文献

1
Prodrugs of peptides. 9. Bioreversible N-alpha-hydroxyalkylation of the peptide bond to effect protection against carboxypeptidase or other proteolytic enzymes.肽的前药。9. 肽键的生物可逆N-α-羟烷基化以实现对羧肽酶或其他蛋白水解酶的保护。
Pharm Res. 1991 Mar;8(3):313-22. doi: 10.1023/a:1015833229554.
2
Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.
Pharm Res. 1991 Dec;8(12):1533-8. doi: 10.1023/a:1015854718903.
3
Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.肽的前药。6. 促甲状腺激素释放激素(TRH)的生物可逆衍生物,具有增加的亲脂性和对TRH特异性血清酶裂解的抗性。
Pharm Res. 1990 Sep;7(9):885-92. doi: 10.1023/a:1015933504191.
4
Transpeptidase activity of Streptomyces D-alanyl-D carboxypeptidases.
Proc Natl Acad Sci U S A. 1972 Mar;69(3):662-6. doi: 10.1073/pnas.69.3.662.
5
Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.
Pharm Res. 1991 Oct;8(10):1238-42. doi: 10.1023/a:1015839426229.
6
Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.肽的前药。IV:通过N-酰化和N-氨甲基化对焦谷氨酰基进行生物可逆衍生化以实现对焦谷氨酰氨肽酶的保护。
J Pharm Sci. 1989 Feb;78(2):122-6. doi: 10.1002/jps.2600780210.
7
Structure and dynamics of the metal site of cadmium-substituted carboxypeptidase A in solution and crystalline states and under steady-state peptide hydrolysis.镉取代羧肽酶A的金属位点在溶液态、晶态及稳态肽水解条件下的结构与动力学
Biochemistry. 1997 Sep 23;36(38):11514-24. doi: 10.1021/bi970936t.
8
Carboxypeptidase-mediated release of methotrexate from methotrexate alpha-peptides.羧肽酶介导的甲氨蝶呤从甲氨蝶呤α-肽中的释放。
Biochemistry. 1989 Mar 7;28(5):2288-97. doi: 10.1021/bi00431a047.
9
Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.包括人类在内的各种动物物种的生物介质中,非对映体阿片肽的氧甲基修饰香豆酸环前药的稳定性。
J Pharm Sci. 2005 Oct;94(10):2198-206. doi: 10.1002/jps.20452.
10
Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means.肽的前药。19. 通过N-酰氧基甲基化及其他方法保护焦谷氨酰残基免受焦谷氨酰氨肽酶的作用。
Acta Pharm Nord. 1992;4(4):301-8.

引用本文的文献

1
Enhancing the buccal mucosal delivery of peptide and protein therapeutics.增强肽和蛋白质治疗药物的颊黏膜给药
Pharm Res. 2015 Jan;32(1):1-21. doi: 10.1007/s11095-014-1485-1. Epub 2014 Aug 29.
2
Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat.
Pharm Res. 1994 Nov;11(11):1640-5. doi: 10.1023/a:1018974107844.
3
Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.
Pharm Res. 1991 Dec;8(12):1533-8. doi: 10.1023/a:1015854718903.
4

本文引用的文献

1
The specificity of carboxypeptidase.羧肽酶的特异性。
J Biol Chem. 1946 Aug;164(2):753-60.
2
The application of peptides containing beta-alanine to the study of the specificity of various peptidases.含β-丙氨酸的肽在各种肽酶特异性研究中的应用。
J Biol Chem. 1948 Sep;175(2):833-48.
3
Structural requirements of specific substrates for carboxypeptidase.羧肽酶特定底物的结构要求
Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.
Pharm Res. 1991 Oct;8(10):1238-42. doi: 10.1023/a:1015839426229.
J Biol Chem. 1949 Dec;181(2):789-802.
4
The specificity of certain peptidases.某些肽酶的特异性。
Adv Enzymol Relat Subj Biochem. 1951;12:191-257. doi: 10.1002/9780470122570.ch4.
5
Synthesis and biological properties of enzyme-resistant analogues of substance P.P物质的酶抗性类似物的合成及生物学特性
Eur J Biochem. 1981 Feb;114(2):329-37. doi: 10.1111/j.1432-1033.1981.tb05152.x.
6
Peptides and related drugs: a review of their absorption, metabolism, and excretion.
Drug Metab Rev. 1986;17(3-4):283-310. doi: 10.3109/03602538608998293.
7
Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
J Med Chem. 1986 Oct;29(10):2088-93. doi: 10.1021/jm00160a049.
8
Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.肽的前药。IV:通过N-酰化和N-氨甲基化对焦谷氨酰基进行生物可逆衍生化以实现对焦谷氨酰氨肽酶的保护。
J Pharm Sci. 1989 Feb;78(2):122-6. doi: 10.1002/jps.2600780210.
9
Prodrug derivatives of thyrotropin-releasing hormone and other peptides.促甲状腺激素释放激素及其他肽类的前药衍生物。
Biochem Soc Trans. 1989 Oct;17(5):947-9. doi: 10.1042/bst0170947.
10
Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.肽的前药。6. 促甲状腺激素释放激素(TRH)的生物可逆衍生物,具有增加的亲脂性和对TRH特异性血清酶裂解的抗性。
Pharm Res. 1990 Sep;7(9):885-92. doi: 10.1023/a:1015933504191.